Research
 

 Mesenchymal Stem Cells (MSC) Isolation

Adipose (Fat) Tissue, Bone Marrow, Umbilical Cord and Cord Blood
 
  DBT Funded Project
   
  Diabetes
1. The Successful completion of SBIRI Project entitled "Differentiation of Human Adipose Tissue Derived Stem Cells to Islet Cell mass Aggregates (ICA) and its preparation for Clinical Application", Ref: BT/SBIRI/1009/6-B20/2012.
   
  Research came to notice of publisher OmniScriptum Publishing Group. They are to publish Aesha's story as a book. Dr. Anant Marathe email: dranantmarathe@hotmail.com is writing the book
   
  Publication
 
  1. Bhaskar K Vyas, Rajni B Vyas, Ansarullah A, Anant Marathe*, Jaymesh M Thadani, Prashant Kshatriya,Dhwani Modi1 and Shivani Vakodikar, Therapeutic Application of Autologous ADMSCS (Adipose Derived Mesenchymal Stem Cells) and Islet like Cell Aggregates (ICAS) Derived from them in Type 1 and 2 Diabetes Mellitus - A Proof of Concept Study, J Stem Cell Res Dev 2016, 3: 008
  2. Jaymesh M Thadani, Anant Marathe, Shivani Vakodikar, Prashant Kshatriya, Dhwani Modi, Rajni Vyas, Bhaskar Vyas, Treatment of Type I Diabetes using Autologous Adipose Derived Mesenchymal Stem Cells Translated to Insulin Secreting Islet like Cell Aggregates, Journal of Case Reports 2017;7(3):235-238.
   
  Osteoarthritis
2. The ongoing BIG Project entitled "A novel therapeutic modality using Adipose derived Mesenchymal Stem Cells (ADMSCs) for treating Osteoarthritis patients & establishing clinical based evidence" has been funded by BIG. Ref No: BIRAC/CCAMP0130/BIG -03/13.
   
  Sir Ganga Ram Hospital, New Delhi; collaboration in process. There are some other hospitals and Orthopedic surgeons in negotiation with us.
   
  Prashant Kshatriya, Anant Marathe, Jaymesh Thadani, Shivani Vakodikar, Rajni Vyas, Ramesh Bhonde, Innovation of a Novel Therapeutic Modality for Treatment of Osteoarthritis of Knee with Autologous Adipose Derived Stromal Vascular Fraction (AD-SVF) Journal of Indian Orthopaedic Rheumatology Association (2017)” Vol.3, Issue. 2.
   
  Publications
 
  1. Anant Marathe, Jaymesh M. Thadani, Prashant Kshatriya, Shivani Vakodikar, Rajni B. Vyas Treatment of Knee Osteoarthritis with Autologous Adipose derived Mesenchymal Stem Cells and Platelet Rich Plasma: a Proof of Concept Study, Journal of Case Report (Accepted Proof)
  2. Prashant Kshatriya, Anant Marathe, Jaymesh Thadani, Shivani Vakodikar, Rajni Vyas, Ramesh Bhonde, Innovation of a Novel Therapeutic Modality for Treatment of Osteoarthritis of Knee with Autologous Adipose Derived Stromal Vascular Fraction (AD-SVF) Journal of Indian Orthopaedic Rheumatology Association (JIORA)” Vol.3, Issue. 2. (Accepted Proof)
   
 
   
   
  Patent
The technology transfer is available for follwoing;
 

1. Diabetes

IP Status: Under Process
Patent application Number: 201621005097
Patent filling Date: 12/2/2016
Patent Title: DIFFERENTIATION OF HUMAN ADIPOSE TISSUE DERIVED STEM CELLS TO ISLET CELL MASS AGGREGATES (ICA) AND ITS USE AS REGENERATIVE MEDICINE FOR DIABETES

2. Osteoarthritis
IP Status: Under process
Patent filling number: 2015/MUM/2015
Patent Date: 04/06/2015
Patent Title: PROCESS OF PREPARING MESENCHYMAL STEM CELLS FOR THE TREATMENT OF OSTEOARTHRITIS AS REGENERATIVE MEDICINE.

3. Retinitis Pigmentosa
Patent Application No.: 201621031994
Dated 20/09/2016
Title “PROCESS OF USING MESENCHYMAL STEM CELLS DERIVED FROM AUTOLOGUS ADIPOSE TISSUE IN TREATING RETINITIS PIGMENTOSA AND RELATED DEGENRATIVE CONDITIONS”
Ref: PTIN/0016131